Brief: Seres Therapeutics Stockholders Approve Sale of VOWST to Nestlé Health Science
26/09/2024 21:03
Sept 26 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS STOCKHOLDERS APPROVE SALE OF VOWST™ TO
NESTLÉ
HEALTH SCIENCE; SALE EXPECTED TO CLOSE ON SEPTEMBER 30
Source text for Eikon: ID:nGNX8ZgM6x
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47